It is also possible to produce DCs in vitro in large numbers (especially cDC2s and pDCs), from CD34+ precursors, capable of inducing a strong anti-tumor response in vitro, with activation of T-lymphocytes and NK cells by cDC2s and pDCs, respectively [160]. Here, CD34 is linked to neoplasm.